Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179110-17-014585
Filing Date
2017-11-22
Accepted
2017-11-22 17:55:04
Documents
1
Period of Report
2017-11-21

Document Format Files

Seq Description Document Type Size
1 FORM 4 - edgar.html 4  
1 FORM 4 - edgar.xml 4 12689
  Complete submission text file 0001179110-17-014585.txt   14053
Mailing Address 38 SIDNEY STREET, SUITE 200 CAMBRIDGE MA 02139
Business Address 38 SIDNEY STREET, SUITE 200 CAMBRIDGE MA 02139 617-374-7580
Blueprint Medicines Corp (Issuer) CIK: 0001597264 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address BLUEPRINT MEDICINES CORPORATION 38 SIDNEY STREET, SUITE 200 CAMBRIDGE MA 02139
Business Address
Dorsch Marion (Reporting) CIK: 0001690460 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37359 | Film No.: 171220787